BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank0
3Y CAGR-23.7%
5Y CAGR-16.8%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-23.7%/yr
vs -4.0%/yr prior
5Y CAGR
-16.8%/yr
Recent deceleration
Acceleration
-19.7pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
8 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.11-8.0%
20240.11-48.1%
20230.22-6.8%
20220.24-7.0%
20210.26-3.5%
20200.26-3.8%
20190.28-1.7%
20180.28-33.1%
20170.42+69.3%
20160.25-